Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIONTECH-SE-66771992/news/BioNTech-and-OncoC4-Present-Positive-Phase-1-2-Data-for-Antibody-Candidate-BNT316-ONC-392-in-Hard-to-44023399/?utm_source=whatsapp&utm_medium=social&utm_campaign=share